Although it is difficult to assess the specific downstream pathway of RET signaling in canine MTC from transcriptomic data alone, the relatively high expression of RET and it’s signaling components suggests activity of this pathway in MTC. This evidence concerns the gene RET and medullary thyroid gland carcinoma.